image

South Korea Business Report

Presented by

Discovery Reports

Optimal patient outcomes achieved using Corentec’s cutting-edge orthopaedic implants

Since its founding in 2000, Corentec has focused on finding innovative methods of surface treatment for orthopaedic implant solutions

PUBLISHED : Wednesday, 25 October, 2017, 10:36am
UPDATED : Wednesday, 25 October, 2017, 10:36am

In an increasingly competitive orthopaedic market, a young and fast-growing South Korean medical device technology company is making a solid global reputation with its higher quality implants and instruments complemented by strong price competitiveness.

Seoul-based Corentec offers cutting-edge orthopaedic implant solutions, encompassing artificial hip and knee joints, spinal implants and bone substitutes. These are recognised for their ease of use and reliability as shown in successful clinical trials and excellent patient outcomes. These implants have been approved, or are in the process of being cleared, by South Korea’s Ministry of Food and Drug Safety and the United States Food and Drug Administration.

“We offer top-tier quality products at reasonable prices compared to those from our multinational rivals in the orthopaedic arthroplasty industry,” says Sonny Hong, president and CEO. “We see vast market opportunities for Corentec as more and more medical institutions are looking for suppliers who offer better quality and service at lower prices.”

Since its founding in 2000, Corentec has focused on finding innovative methods of surface treatment for orthopaedic implant solutions. Its micro arc oxidation (MAO) technology is acclaimed for delivering improved bone in-growth and on-growth in patients who are recovering from arthroplasty surgery. In 2010, the MAO technology was given the Otto Aufranc Award by the American Association of Orthopaedic Surgeons. Last year, Corentec unveiled metal 3D-printed implants using direct energy deposition technology.

“We have always put innovations first,” Hong says. “We don’t follow our competitors’ pathways.”

Building on its success in its home market and the US, Corentec seeks to strengthen its foothold in Asia through strategic collaborations. It welcomes partners who can develop instruments or have technology capabilities in metal tooling, particularly casting or forging of medical-grade titanium and cobalt-chromium-molybdenum alloy. Corentec also aims to connect with Asia’s high-producing distributors who have established relationships with leading orthopaedic surgeons and health care providers.

www.corentec.com